[go: up one dir, main page]

EE200100062A - Uued 2,3,3a,4,9,9a-heksahüdro-8-hydroxy-1H-bens(f)indoolid, meetodid nende valmistamiseks ja nende kasutamine ravimitena - Google Patents

Uued 2,3,3a,4,9,9a-heksahüdro-8-hydroxy-1H-bens(f)indoolid, meetodid nende valmistamiseks ja nende kasutamine ravimitena

Info

Publication number
EE200100062A
EE200100062A EEP200100062A EEP200100062A EE200100062A EE 200100062 A EE200100062 A EE 200100062A EE P200100062 A EEP200100062 A EE P200100062A EE P200100062 A EEP200100062 A EE P200100062A EE 200100062 A EE200100062 A EE 200100062A
Authority
EE
Estonia
Prior art keywords
indoles
benz
hexahydro
pharmaceuticals
hydroxy
Prior art date
Application number
EEP200100062A
Other languages
English (en)
Estonian (et)
Inventor
Grauert Matthias
Hoenke Christoph
Carter Adrian
Bechtel Wolf-Dietrich
Weiser Thomas
Palluk Rainer
Pschorn Uwe
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100062A publication Critical patent/EE200100062A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100062A 1998-07-31 1999-07-22 Uued 2,3,3a,4,9,9a-heksahüdro-8-hydroxy-1H-bens(f)indoolid, meetodid nende valmistamiseks ja nende kasutamine ravimitena EE200100062A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834714A DE19834714A1 (de) 1998-07-31 1998-07-31 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/005222 WO2000007986A1 (fr) 1998-07-31 1999-07-22 Nouveaux 2,3,3,a,4,9,9a-hexahydro-8-hydroxy-1h-benz[f] indoles, leurs procedes de preparation et leur utilisation comme medicament

Publications (1)

Publication Number Publication Date
EE200100062A true EE200100062A (et) 2002-06-17

Family

ID=7876092

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100062A EE200100062A (et) 1998-07-31 1999-07-22 Uued 2,3,3a,4,9,9a-heksahüdro-8-hydroxy-1H-bens(f)indoolid, meetodid nende valmistamiseks ja nende kasutamine ravimitena

Country Status (29)

Country Link
US (1) US6051583A (fr)
EP (1) EP1100780B1 (fr)
JP (1) JP2002522418A (fr)
KR (1) KR20010072142A (fr)
CN (1) CN1147470C (fr)
AT (1) ATE360611T1 (fr)
AU (1) AU763834B2 (fr)
BG (1) BG105178A (fr)
BR (1) BR9912605A (fr)
CA (1) CA2336783C (fr)
CO (1) CO5080748A1 (fr)
DE (2) DE19834714A1 (fr)
EA (1) EA003370B1 (fr)
EE (1) EE200100062A (fr)
ES (1) ES2285851T3 (fr)
HU (1) HUP0103518A3 (fr)
ID (1) ID28292A (fr)
IL (1) IL140863A0 (fr)
MY (1) MY133085A (fr)
NO (1) NO20010513L (fr)
NZ (1) NZ510246A (fr)
PL (1) PL345808A1 (fr)
SK (1) SK1502001A3 (fr)
TR (1) TR200100316T2 (fr)
TW (1) TW464643B (fr)
UA (1) UA68388C2 (fr)
WO (1) WO2000007986A1 (fr)
YU (1) YU5501A (fr)
ZA (1) ZA200007770B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
WO2003057219A1 (fr) * 2001-12-27 2003-07-17 Ortho-Mcneil Pharmaceutical Inc. Arylpyrrole heteroaryle et methanols utilises pour le traitement de troubles du systeme nerveux central

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0151699B1 (ko) * 1989-07-13 1998-10-15 로버트 에이. 아미테이지 (1,2n) 및 (3,2n)-카보사이클릭-2-아미노테트랄린 유도체
AU2153592A (en) * 1991-05-20 1993-01-08 Upjohn Company, The Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
YU5501A (sh) 2003-04-30
ID28292A (id) 2001-05-10
UA68388C2 (en) 2004-08-16
KR20010072142A (ko) 2001-07-31
DE19834714A1 (de) 2000-02-03
CA2336783C (fr) 2009-04-28
EP1100780A1 (fr) 2001-05-23
ATE360611T1 (de) 2007-05-15
MY133085A (en) 2007-10-31
PL345808A1 (en) 2002-01-02
CN1147470C (zh) 2004-04-28
HUP0103518A2 (hu) 2002-01-28
EP1100780B1 (fr) 2007-04-25
EA003370B1 (ru) 2003-04-24
AU5162699A (en) 2000-02-28
HK1038017A1 (en) 2002-03-01
TR200100316T2 (tr) 2001-07-23
HUP0103518A3 (en) 2002-12-28
NO20010513D0 (no) 2001-01-30
ES2285851T3 (es) 2007-11-16
CA2336783A1 (fr) 2000-02-17
NZ510246A (en) 2003-08-29
CN1310707A (zh) 2001-08-29
SK1502001A3 (en) 2001-09-11
JP2002522418A (ja) 2002-07-23
BR9912605A (pt) 2001-05-02
CO5080748A1 (es) 2001-09-25
IL140863A0 (en) 2002-02-10
ZA200007770B (en) 2002-01-17
BG105178A (bg) 2001-12-29
WO2000007986A1 (fr) 2000-02-17
NO20010513L (no) 2001-01-30
AU763834B2 (en) 2003-07-31
US6051583A (en) 2000-04-18
EA200100107A1 (ru) 2001-08-27
DE59914314D1 (de) 2007-06-06
TW464643B (en) 2001-11-21

Similar Documents

Publication Publication Date Title
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
CY2013003I2 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
EE04739B1 (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
FI952550A7 (fi) Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE200000651A (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200000129A (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI953956L (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
EE04680B1 (et) Tritsklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod

Legal Events

Date Code Title Description
HC1A Change of owner name